Craneware’s (CRW) Buy Rating Reiterated at Shore Capital

Shore Capital reaffirmed their buy rating on shares of Craneware (LON:CRW) in a research note published on Tuesday, Marketbeat reports. They currently have a GBX 2,850 price target on the stock.

A number of other brokerages have also recently commented on CRW. Berenberg Bank lifted their target price on shares of Craneware from GBX 2,800 to GBX 2,900 and gave the stock a “buy” rating in a research report on Monday. Peel Hunt reiterated a “buy” rating and issued a GBX 2,871 target price on shares of Craneware in a research report on Monday. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of GBX 2,873.67.

Craneware Stock Performance

LON CRW opened at GBX 2,400 on Tuesday. Craneware has a 52-week low of GBX 1,330 and a 52-week high of GBX 2,620. The company has a debt-to-equity ratio of 12.22, a quick ratio of 1.00 and a current ratio of 0.63. The company has a market capitalization of £849.84 million, a P/E ratio of 5,647.06 and a beta of 0.28. The company has a fifty day moving average of GBX 2,292.54 and a 200-day moving average of GBX 2,032.46.

About Craneware

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group’s Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.